Electromed, Inc.

NYSE American ELMD

Electromed, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD 8.38 M

Electromed, Inc. Operating Income is USD 8.38 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 104.02% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Electromed, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 4.11 M, a 76.98% change year over year.
  • Electromed, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 2.32 M, a -23.07% change year over year.
  • Electromed, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 3.02 M, a -31.97% change year over year.
  • Electromed, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 4.43 M, a 11.72% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
NYSE American: ELMD

Electromed, Inc.

CEO Mr. James L. Cunniff
IPO Date Aug. 13, 2010
Location United States
Headquarters 500 Sixth Avenue NW
Employees 174
Sector Health Care
Industries
Description

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Similar companies

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

IRMD

IRadimed Corporation

USD 57.52

1.79%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email